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Cycles of Early Drosophila Embryogenesis
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The nuclear division cycles of early Drosophila embryogenesis have a number of unique features that distinguish them from
later cell cycles. These features include the lack of some checkpoints that operate in later cell cycles, the absence of gap
phases, and very rapid DNA synthesis phases. The molecular mechanisms that control these rapid nuclear division cycles
are poorly understood. Here we describe analysis of cyclin J, a previously uncharacterized cyclin which has an RNA
expression pattern that suggests a possible role in early embryogenesis. We show that the cyclin J protein is present in early
embryos where it forms active kinase complexes with cyclin-dependent kinase (Cdk) 2. To determine whether cyclin J plays
a role in controlling the early nuclear cycles we isolated peptide aptamers that specifically bind to cyclin J and inhibit its
ability to activate Cdks. We injected the inhibitory aptamers into syncytial Drosophila embryos and demonstrated that they
aused defects in chromosome segregation and progression through mitosis. We obtained similar results by injecting cyclin
antibodies into embryos. Our results suggest that a cyclin J-associated kinase activity is required for the early embryonic
ivision cycles. © 2000 Academic Press
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In Drosophila, as in other multicellular organisms, cell
ivision is controlled by a highly conserved family of
roteins called cyclin-dependent kinases (Cdks) and their
egulatory subunits, the cyclins (reviewed in Morgan, 1995;
dgar and Lehner, 1996). Orderly progression through a
ypical somatic cell cycle requires the cyclic activity of
everal distinct Cdk/cyclin complexes. The transition from
he G2 phase to mitosis (M) requires active complexes
onsisting of Cdk1 and one of the mitotic cyclins, the A- or
-type cyclins, which accumulate during interphase (Leh-
er and O’Farrell, 1990; Knoblich and Lehner, 1993; Jacobs
t al., 1998). Exit from M phase requires the loss of Cdk1
ctivity that results from sequential proteolytic degradation
f the mitotic cyclins (Dawson et al., 1995; Sigrist et al.,
995). Entry into the DNA synthesis (S) phase requires the
ctivity of Cdk2, which forms complexes with cyclin E in
ate G1 phase (Knoblich et al., 1994). A number of other
rosophila Cdks and cyclins have been identified but their
oles in regulation of the cell cycle have not been deter-
ined (Lahue et al., 1991; Leopold and O’Farrell, 1991;inley et al., 1996; Sauer et al., 1996). Some of these
0012-1606/00 $35.00
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cell cycle regulation in specific developmental contexts.
In most multicellular organisms the cell division cycles
during early embryogenesis have unique properties that
distinguish them from the cell cycles in later development.
This is particularly evident in Drosophila, in which the
initial 13 nuclear division cycles of embryogenesis take
place in near synchrony within a common cytoplasm, or
syncytium (reviewed in Foe et al., 1993). These cycles
consist of alternating S and M phases, without the inter-
vening gap phases that appear later in development. The
nuclear cycles are also much faster than the typical somatic
cell cycle; cycles 2–9 last as little as 8 min each and the
entire genome is duplicated in as little as 5 min (Spradling
and Orr-Weaver, 1987). Finally, the first 10 divisions appear
to lack the checkpoint which in later cell cycles blocks
entry into M phase in the presence of damaged or unrepli-
cated DNA (Togashi and Okada, 1984; Raff and Glover,
1988; Sullivan et al., 1993). The molecular mechanisms
that control the embryonic nuclear division cycles and that
account for their unique features are largely unknown.
The syncytial embryo is supplied with maternal stores of























662 Kolonin and Finleytypical cell cycles later in development. For example, Cdk1
and Cdk2 are both abundant in the early embryo, as are
cyclins A, B, B3, and E (Lehner and O’Farrell, 1989; Whit-
field et al., 1990; Richardson et al., 1993; Edgar et al., 1994;
Sauer et al., 1995; Jacobs et al., 1998). Maternal Cdk1 and
cyclin B have been shown to be required for the early
embryonic cycles (Stern et al., 1993; Stiffler et al., 1999),
whereas a requirement for the other Cdks and cyclins has
not yet been demonstrated. At least some of the unique
features of the nuclear division cycles may be mediated by
novel regulation of these cell cycle proteins. For example, in
contrast to later cycles, the overall levels of cyclin A and
cyclin B do not oscillate during the early nuclear division
cycles (Edgar et al., 1994). Instead, exit from mitosis coin-
cides with localized degradation of mitotic cyclins and
localized Cdk1 inactivation along the chromosomes (Su et
al., 1998). Here we show that in addition to this embryo-
specific regulation of known Cdks and cyclins, the early
embryo contains a novel cyclin, cyclin J, which may con-
tribute to some of the unique features of the nuclear
division cycles.
Cyclin J was previously identified in a yeast two-hybrid
screen for embryonic proteins that interact with Cdk2
(Finley et al., 1996). The amino acid sequence of cyclin J is
most similar to that of the A-type cyclins, but lacks the
destruction box and other consensus motifs found in all
mitotic cyclins. Cyclin J mRNA is present in the embryo
prior to cellularization but, in contrast with other cyclins,
is not expressed later in embryogenesis (Finley et al., 1996).
Here we show that cyclin J protein is present in the
syncytial embryo in active complexes with Cdk2. Cyclin J
protein and the associated kinase activity are downregu-
lated during later embryonic development, prior to down-
regulation of cyclins A, B, B3, and E. To test the importance
of cyclin J in the early embryo we isolated peptide aptamers
that specifically inhibit the cyclin J-associated kinase activ-
ity and injected them into embryos. We show that these
peptide aptamers, as well as cyclin J antibodies, inhibit
nuclear divisions in the early embryos.
MATERIALS AND METHODS
Drosophila Manipulations
The stock carrying a homozygous UAS-cycJ insertion in the
econd chromosome was constructed by P-element-mediated
ransformation of w 1118 embryos (Spradling and Rubin, 1982) with
MK4-CycJ. pMK4, a P-element vector designed for deposition of
aternally transcribed transgenic mRNA into eggs, was con-
tructed by inserting the 39 UTR of a-tubulin 1 (Theurkauf et al.,
1986) between the polylinker and the SV40 terminator of pUAST
(Brand and Perrimon, 1993). pMK4-CycJ was constructed by insert-
ing an EcoRI–MunI fragment containing the cycJ cDNA clone,
Cdi5, derived from pJG4-5-Cdi5 (Finley et al., 1996) into pMK4 cut
with EcoRI. The Cdi5 clone contains the entire coding region of
cycJ cDNA plus 15 bp upstream of the ATG and 114 bp of 39 UTR
after the stop codon. Analysis of endogenous cyclin J expression
and microinjections were performed using w1118. Analysis of ectopi- 1
Copyright © 2000 by Academic Press. All rightally expressed cyclin J was performed in the progeny of parents
roduced by crossing males carrying a homozygous UAS-cycJ or a
AS-lacZ (Bloomington No. 1776) transgene with females carrying
homozygous hsp70-GAL4 (Bloomington No. 1799) or a prd-GAL4
Bloomington No. 1947) transgene. Induction of ectopic cycJ or
acZ expression in hsp70-GAL4 embryos was performed by incu-
ating egg collection plates at 37°C for 2 h followed by a recovery
eriod at 25°C for 30 min prior to protein extraction or embryo
xation.
Affinity Purification
cycJ cDNA was PCR-amplified from pJG4-5-Cdi5 (Finley et al.,
1996) using primers 59-GAGAGAATTCCTGACCGACTATC-
ATTATTACC-39 and BCO2 (Finley and Brent, 1995). The PCR
product was cut with EcoRI and XhoI and inserted into pMAL-c2
(NEB) for expression of MBP fusions, pGEX2 for GST fusions, or
pET28a (Novagen) for His6 fusions. An EcoRI–XhoI Dacapo (Dap)
fragment encoding amino acids 21 to 245 of Dap from pJG4-5-Cdi4
(Finley and Brent, 1994) was expressed from pMAL-c2 (NEB).
EcoRI–SalI fragments encoding trxA-fused JA1, JA2, PepC2, or DA2
were isolated from pJM-1 (Colas et al., 1996) and inserted into
pET28a. MBP and GST fusions were expressed in SURE Esche-
ichia coli (Stratagene) and affinity-purified using amylose resin
NEB) or glutathione–Sepharose 4B (Pharmacia), respectively. His6
fusions were expressed in BL21/DE3 E. coli (Novagen) and affinity-
purified using Ni-NTA agarose (Qiagen). Rabbit polyclonal cyclin J
antibodies were affinity-purified using His6-CycJc immobilized on
Ni-NTA agarose (Qiagen) or GST-CycJc immobilized on Affi-Gel
15 (Bio-Rad). Purified peptides and antibodies were concentrated
and buffer-equilibrated using Centricon filters (Amicon).
Immunoblots, Immunoprecipitations, and Histone
H1 Kinase Assays
Cyclin J was immunodetected with mouse polyclonal or affinity-
purified rabbit polyclonal antibodies raised against MBP-CycJc.
Dechorionated embryos, larvae, or adult flies were Dounce-
homogenized in lysis buffer (150 mM NaCl, 1% NP-40, 10%
glycerol, 50 mM Tris–HCl, pH 8.0) containing 2.5 mM EDTA,
0.02% NaN3, 20 mM NaF, 0.3 mM Na3VO4, 1 mM PMSF, 1 mg/ml
pepstatin A, 1 mg/ml aprotinin, 10 mg/ml chymostatin, 2 mg/ml
leupeptin, 0.1 mg/ml TPCK, and 10 mg/ml soybean trypsin inhib-
itor. Extracts with approximately 20 mg/ml protein were cleared by
centrifugation and frozen at 280°C until use. For each immuno-
precipitation, 100 ml of protein A–Sepharose 6MB beads (Pharma-
ia) diluted 10-fold in lysis buffer was coated for 1 h at 4°C with 3
mg of affinity-purified cyclin J antibodies. For control experiments,
protein A- or protein G-agarose (Gibco BRL) beads were coated with
a similar amount of polyclonal cyclin B antibodies, Rb271 (gift
from D. Glover) or polyclonal rat cyclin E antibodies (gift from H.
Richardson), respectively. Beads were rocked for 1 h at 4°C with 5
mg of protein extract and then washed three times with 0.5 ml of
lysis buffer. For competition experiments, immunoprecipitations
were performed in the presence of 2.5 mM MBP-CycJc or MBP-
PepC2. For immunoblots, beads were boiled for 5 min in 30 ml of
DS sample buffer, cleared by centrifugation, and resolved on a
0% SDS–PAGE gel. Immunoblotting was performed using
ybond-P membranes and ECL Plus detection kit (Amersham). All
ycJ antibodies, as well as cyclin B antibodies Rb271, were used at
:2000 dilution. Affinity-purified rabbit antibodies against Dro-




































663Cyclin J in Early Drosophila Embryogenesissophila Cdk1 and Cdk2 (gift from C. Lehner) were each used at
1:1000 dilution. For H1 kinase assays, beads with immunoprecipi-
tates were washed with 1 ml of 13 kinase buffer (50 mM Hepes, pH
.5, 10 mM MgCl2, 1 mM DTT) and then incubated for 30 min at
°C in the presence or absence of 5 ml of a purified peptide,
BP-Dap, or buffer. The kinase reaction was initiated by addition
f 10 ml of 13 kinase buffer containing 200 mg/ml histone H1
Sigma), 60 mM ATP, and 0.2 mCi/ml [g-32P]ATP. After 30 min of
incubation at 25°C, 10 ml of SDS sample buffer was added; the
samples were boiled for 5 min and run on 12% SDS–PAGE for
subsequent autoradiography.
Immunostaining
Dechorionated embryos were fixed for 20 min in a two-phase
mixture of equal volumes of heptane and PEM (100 mM Pipes, pH
6.9, 1 mM MgCl2, 1 mM EGTA) 1 3.7% formaldehyde. Devitell-
inization was performed by replacing the aqueous phase with
methanol and shaking for 30 s. Devitellinized embryos were
washed for 10 min with methanol and twice for 10 min with PBS 1
0.2% saponin, blocked for 1 h at room temperature in PBS 1 0.2%
aponin 1 10% normal goat serum, and incubated with primary
ntibodies in PBS 1 0.2% saponin overnight at 4°C. Primary
ntibodies were washed off with PBS 1 0.2% saponin three times
or 10 min and secondary antibodies were applied for 1 h at 25°C.
inally, embryos were washed with PBS 1 0.2% saponin three
imes for 10 min and stained for DNA in 1 mg/ml Hoechst 33258 for
10 min. Samples were mounted in Fluoromount G (immunofluo-
rescence) or Aquamount (immunohistochemistry), and digital im-
ages were captured using a Nikon Optiphot EFD-3 microscope and
Photometrix Sensys digital camera setup. Cyclin J was detected
using affinity-purified rabbit CycJ antibodies diluted 1:100. His6-
fused peptides were detected with a monoclonal antibody against
the T7 tag (Novagen) at 1:100 dilution. Secondary Texas red-
conjugated goat anti-mouse, FITZ-conjugated goat anti-rabbit
(Jackson Laboratories), and HRP-conjugated goat anti-rabbit anti-
bodies (Bio-Rad) were each used at 1:250 dilution.
Yeast Manipulations
Protein interaction assays and interactor hunts were performed
using the version of the yeast two-hybrid system (Fields and
Sternglanz, 1994) developed by Brent and colleagues (Golemis et
al., 2000). For additional details see http://cmmg.biosci.wayne.edu/
rfinley/lab.html. LexA-cyclin J (Finley and Brent, 1994) was used to
screen a Drosophila ovary cDNA library RFLY3 (Finley et al.,
996). Yeast transformants (7.7 3 106) were screened and 40
galactose-dependent positives were isolated, 6 of which were Cdk2,
13 of which were Cdk1 lacking the N-terminal 17 amino acids, 1 of
which was Scf, 2 of which were Arl2, 17 of which were S5a, and 1
of which was a novel protein named Dm5-306. To isolate cyclin J
peptide aptamers a random peptide library pYENAeTRX (Colas et
al., 1996) was screened by interaction mating as described (Kolonin
and Finley, 1998). From 2.4 3 107 yeast transformants, 29
alactose-dependent positives were isolated, 7 of which activated
he reporters better than any of the Drosophila cyclin J-interacting
roteins. The specificity of all interactors was tested with the
nteraction mating assay (Finley and Brent, 1994). LexA-cyclin D
nd LexA-Cln3 bait plasmids have been described previously
Finley and Brent, 1994). LexA-cyclin C and LexA-cyclin A bait
lasmids were constructed by inserting an EcoRI–XhoI fragment
ontaining Drosophila cyclin C cDNA or an EcoRI–BamHI frag- s
Copyright © 2000 by Academic Press. All rightent containing Drosophila cyclin A cDNA into the correspond-
ng sites of pEG202 or pGilda (Golemis et al., 2000), respectively.
ln2 complementation was performed as described (Finley et al.,
1996). Drosophila cyclins were expressed from pRF80, a URA3, 2
mm vector containing a translational start signal flanked by an
ADH1 promoter/terminator expression cassette (R.L.F., unpub-
lished). TrxA-fused peptides were expressed from pJM-1 (Colas et
l., 1996). Cyclin J aptamers had the following sequences: JA1,
LRHSGSGWTAWLEMAVEGA; JA2, LVWRPLRGGSEGFLNLL-
RG; and JA3, CVRHIWMVGLLCCRYLFAG.
Embryo Injection
Dechorionated embryos were aligned on the edge of a glass slide
coated with heptane-based glue for 10 min, covered with holocar-
bon oil, and injected with peptides, affinity-purified antibodies, or
preimmune serum in 5 mM NaCl, 0.1 mM NaHPO4 (pH 7.7) at a
oncentration of 2.5 mg/ml. The injected volume was estimated to
e 1–5% of the total embryo volume. Injected embryos were aged at
8°C for 0–20 min (peptides) and 0–30 min (affinity-purified
ntibodies and serum). Embryos were then released in heptane and
xed with gentle rotation for 5 min at the interphase of equal
olumes of heptane and 37% formaldehyde. Fixed embryos were
pread on a Nitex mesh, washed with PBS, and attached to
ouble-stick tape for manual devitellinization and subsequent
mmunostaining.
RESULTS
Cyclin J Protein Is Present in Early Embryos
To determine whether cyclin J protein is present during
early embryogenesis we used rabbit antibodies raised
against the unique C-terminal 100 amino acids of cyclin J
(CycJc). Affinity-purified cyclin J antibodies recognized a
single protein of the appropriate molecular weight (;50
kDa) in immunoblots from early embryos (Fig. 1a). The
abundance of this protein diminished during embryogen-
esis, yet could be dramatically induced in older embryos
that carried a heat-shock-inducible cyclin J transgene (hs .
CycJ) (Fig. 1a). The cyclin J protein was abundant in
unfertilized eggs and in embryos 0–1.5 h after egg deposi-
tion (AED), but diminished to a low level by 3 h AED (Fig.
1a). A similar pattern was observed by immunoprecipitat-
ing proteins from embryo extracts using the affinity-
purified rabbit cyclin J antibodies and probing immunoblots
using a mouse antisera raised against CycJc; cyclin J protein
was detected in unfertilized and 0- to 3-h-old embryos, but
could not be detected in older embryos (Fig. 1b). Under the
conditions used to stage these embryos, cellularization is
completed between 2 and 3 h AED. Thus, cyclin J is most
abundant in the syncytial embryo. This pattern is in con-
trast to the expression profile of cyclin B, which is abundant
throughout embryogenesis (Fig. 1a), and of cyclins A, B3,
and E, which are expressed in a temporal pattern similar to
that of cyclin B (Lehner and O’Farrell, 1989; Whitfield et al.,
1990; Richardson et al., 1993; Jacobs et al., 1998).
Consistent with the immunoblots, the cyclin J antibodies
trongly stained wild-type embryos undergoing the first 10










664 Kolonin and Finleydivisions (Fig. 2a). Starting at late syncytial stages embryo
staining decreased to a background level (Figs. 2b–2d; data
not shown). Cyclin J staining could be induced in later
embryos that contained the hs . CycJ transgene (Fig. 2e) or
n a striped pattern in embryos expressing CycJ under
ontrol of the prd promoter (data not shown). We observed
o obvious subcellular localization in the early embryos or
s . CycJ embryos. In adult Drosophila cyclin J staining
as strong in the cytoplasm of the ovarian nurse cells, but
as not detected in testes in males (data not shown).
ombined, our data suggest that cyclin J protein is depos-
ted into eggs maternally and is degraded during early
FIG. 1. Cyclin J protein is present in early embryos. (a) 10 mg of
protein from the indicated stages was loaded per lane and immu-
noblotted with affinity-purified rabbit cyclin J antibodies or cyclin
B antibodies. The cyclin J band migrating at an apparent molecular
weight of 50 kDa (arrowhead) is detectable in wild-type females,
unfertilized embryos, and embryos of the indicated ages and is
induced in heat-shocked 3- to 20-h-old hsp70-GAL4/UAS-cycJ
embryos (hs . J). Cyclin J is not detectable in wild-type males or in
an equal mixture of L1–L3 stage larvae (L1–L3). (b) Protein com-
plexes were immunoprecipitated with the affinity-purified rabbit
cyclin J antibodies from embryos of the indicated ages and immu-
noblotted with mouse polyclonal cyclin J antibodies. The cross-
reacting IgG band is indicated with an asterisk.mbryogenesis.
Copyright © 2000 by Academic Press. All rightFIG. 2. Immunohistochemical detection of cyclin J in embryos.
Staining with affinity-purified cyclin J antibodies in wild-type
embryos (a–c) or in heat-shocked stage 12 hsp70-GAL4/UAS-lacZ
(d) or hsp70-GAL4/UAS-cycJ (e) embryos. The wild-type embryos
are at stage 2 during the first nuclear divisions (a), at stage 5 during
cellularization (b), and at stage 11 during mitosis 16 in the
epidermis (c). Staining (dark) was detected with HRP-conjugated
secondary antibodies.
































































665Cyclin J in Early Drosophila EmbryogenesisCyclin J Interacts with Cdk2 in Early Embryos
To identify proteins that may form complexes with
cyclin J, we used the two-hybrid system to screen two
Drosophila cDNA libraries, one from ovaries and one from
embryos (Fig. 3a). In addition to Cdk2, we isolated three
other cyclin J-interacting proteins from the libraries. We
isolated full-length versions of the DNA supercoiling factor
Scf (Kobayashi et al., 1998) and of a putative GTPase, Arl2
(Clark et al., 1993), and the carboxy-terminal 371 amino
cids of S5a, the non-ATPase subunit of the 26S proteasome
Haracska and Udvardy, 1995). Each of these proteins, as
ell as the Cdk subunit Cks1, which previously had been
hown to bind to cyclin J (Finley and Brent, 1994), inter-
cted specifically with cyclin J but not with a panel of
nrelated proteins in the two-hybrid assay (Fig. 3a; data not
hown). We did not isolate any full-length Cdks other than
dk2. Moreover, in direct tests, cyclin J failed to interact
ith other Cdks, including Cdk1 (Fig. 3a), Cdk4, and Cdk5
data not shown). These results suggested that Cdk2 may be
he kinase partner for cyclin J.
To determine whether Cdk2 interacts with cyclin J in
rosophila, we used affinity-purified cyclin J antibodies to
recipitate cyclin J complexes from embryo extracts. We
ubjected the precipitates to immunoblotting with Cdk1 or
dk2 antibodies (Fig. 3b). Consistent with the two-hybrid
nteractions, Cdk2 and cyclin J coimmunoprecipitated from
nfertilized eggs and syncytial embryos. The cyclin J com-
lexes contained both of the previously described phos-
hoisoforms (Sauer et al., 1995) of Cdk2 (Fig. 3b). We did not
etect coimmunoprecipitation of cyclin J and Cdk2 from
lder embryos, unless the embryos ectopically expressed
yclin J from the hs . CycJ transgene (Fig. 3b). Cdk1 was
ot detected in complexes with cyclin J in early embryos.
owever, we did detect Cdk1 in cyclin J immunoprecipi-
ates from unfertilized eggs and from older hs . CycJ
mbryos (Fig. 3b). Combined, these results suggest that
yclin J can bind both Cdk1 and Cdk2 in vivo and that Cdk2
s the principal kinase subunit for cyclin J in the syncytial
mbryo.
Early Embryos Contain a Cyclin J-Associated
Kinase Activity
To determine whether cyclin J is associated with an
active kinase in embryos we tested cyclin J immunoprecipi-
tates for their ability to phosphorylate histone H1. We
detected cyclin J-associated H1 kinase activity in newly laid
unfertilized eggs and embryos 0–4 h AED (Fig. 4a). The
activity diminished between 3 and 6 h and after 6 h reached
the background level that can be immunoprecipitated with
preimmune serum (Figs. 4a and 4b; data not shown). Pre-
cipitation of the cyclin J-associated kinase activity from
both syncytial embryos and later embryos that ectopically
expressed cyclin J was blocked by CycJc peptide, but not by
a control peptide, PepC2 (Fig. 4b). In contrast, CycJc did not
block immunoprecipitation of cyclin B-associated H1 ki-
nase activity or the background activity (Fig. 4b). These T
Copyright © 2000 by Academic Press. All rightata, combined with the results from coimmunoprecipita-
ions and two-hybrid interaction assays, suggest that early
mbryos contain active Cdk2/cyclin J complexes which are
nactivated around the time of cellularization by degrada-
ion of cyclin J.
Isolation of Peptide Aptamers to Specifically
Inhibit Cyclin J in Vivo
A useful approach to studying the early embryonic divi-
sion cycles has been to inject embryos with antibodies or
small molecules that specifically inhibit maternally depos-
ited proteins (Raff and Glover, 1988; Schubiger and Edgar,
1994; Su et al., 1997, 1998). To investigate the function of
yclin J in early development, we set out to isolate peptides
hat could be injected into living embryos to interfere with
yclin J function. First we identified peptide aptamers that
ind specifically to cyclin J. We screened a yeast two-hybrid
ibrary that expresses random 20 amino acid peptides on the
urface of a platform molecule, E. coli thioredoxin (trxA)
Colas et al., 1996), and isolated a number of trxA-fused
eptides that interacted with cyclin J. Several of the cyclin
-interacting peptides (JA1, JA2, and JA3) interacted specifi-
ally with cyclin J but not with Drosophila cyclins A, D, or
(Fig. 3a) or cyclins E or H (data not shown). A control
rxA-fused peptide, PepC2 (Colas et al., 1996), or a peptide
ptamer specific for cyclin D, DA2, did not interact with
yclin J (Fig. 3a). The sequences of the cyclin J aptamers
hared no strong similarity with each other or with previ-
usly identified proteins (see Materials and Methods).
To determine whether the cyclin J peptide aptamers
ould interfere with cyclin J function, we tested their
bility to inhibit cyclin J-associated kinase activity. We
mmunoprecipitated cyclin complexes from embryo ex-
racts with affinity-purified cyclin J antibodies and assayed
he H1 kinase activity of the complexes in the presence or
bsence of purified trxA-fused peptides. In these experi-
ents the peptides were incubated with the complexes
fter immunoprecipitation. As shown in Fig. 5, the cyclin
-associated kinase activity in the precipitates was inhibited
y aptamer JA1 and JA2 at peptide concentrations of 1 to 10
mM, but not by the control peptide, pepC2. JA1 and JA2
inhibited the cyclin J kinase immunoprecipitated from
syncytial embryos (Fig. 5a) and from later embryos that
ectopically expressed cyclin J (Fig. 5b); the later extracts
may contain cyclin J in complexes with Cdk1 in addition to
Cdk2 (Fig. 3b). In contrast, the cyclin J aptamers did not
inhibit cyclin B- or cyclin E-associated kinase activities
(Fig. 5b). To compare the effects of JA1 and JA2 with those
of known Cdk inhibitors, we tested cyclin J- and
E-associated kinases for inhibition by a Cdk2 inhibitor Dap.
As reported previously (de Nooij et al., 1996; Lane et al.,
996), Dap efficiently inhibited cyclin E-associated kinase
ctivity (Fig. 5c). Dap also inhibited the cyclin J-associated
inase with half-maximal inhibition at 1–3 mM (Fig. 5c).
hese results indicate that the cyclin J aptamers inhibit
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Copyright © 2000 by Academic Press. All rightcyclin J kinase with efficiencies comparable to that of a
natural Cdk inhibitor.
We used a functional assay in yeast to test whether the
cyclin J aptamers could inhibit cyclin J in living cells (Fig.
6). Like many other cyclins, Drosophila cyclin J is able to
omplement cln2 mutant yeast which lack the three yeast
1 cyclins, CLN1, CLN2, and CLN3 (Finley et al., 1996).
e expressed trxA-fused JA1, JA2, or pepC2 in strains of
ln2 yeast that depended on a Drosophila cyclin for growth.
he cyclin J peptide aptamers dramatically inhibited the
rowth of cyclin J-dependent yeast (Fig. 6). In contrast,
either aptamer interfered with growth of strains depen-
ent on Drosophila cyclin E (Fig. 6) or cyclin D (data not
hown), indicating that the inhibition was specific for
from extracts of wild-type embryos at the indicated stages or
heat-shocked 3- to 20-h-old hsp70-GAL4/UAS-cycJ embryos (hs .
J). The precipitates were immunoblotted with antibodies specific
for Drosophila Cdk1 (bottom) or Cdk2 (top). Cyclin J associates
FIG. 4. Cyclin J is associated with an active kinase in early
embryos. Protein complexes immunoprecipitated from Drosophila
xtracts with cyclin J affinity-purified antibodies (IP-CycJ) or cyclin
antibodies (IP-CycB) were used in H1 kinase assays. (a) Extracts
ere derived from wild-type unfertilized eggs, staged embryos
eveloped for the indicated time intervals, an equal mixture of
1–L3 stage larvae (L1–L3), or heat-shocked 3- to 20-h-old hsp70-
AL4/UAS-cycJ embryos (hs . J). (b) Protein complexes were
mmunoprecipitated from the indicated extracts in the presence (1)
or absence (2) of 2.5 mM control peptide MBP-PepC2 or 2.5 mM
BP-CycJc. The position of phosphorylated H1 on the gel is
ndicated with an arrowhead.FIG. 3. Interaction of cyclin J with Drosophila proteins and
eptide aptamers. (a) Yeast two-hybrid mating assay. Strains ex-
ressing the indicated LexA-fused cyclins in rows were mated with
trains expressing the indicated activation domain-fused proteins
r peptides in columns, and the resulting strains were assayed for
nteraction by replicating diploid cells to indicator plates. An
nteraction results in growth on leucine dropout (leu2) plates
(white patches) or blue staining on X-Gal plates (blue patches). The
LEU2 reporter is more sensitive than the lacZ reporter and registers
weaker interactions. JA1–JA3, cyclin J aptamers; DA2, cyclin D
aptamer; pepC2, control peptide. Because cyclin A is toxic to yeast,
the CycA interactions were assayed by patching diploid cells to
indicator plates. (b) Protein complexes were immunoprecipitated
with affinity-purified cyclin J antibodies (IP-CycJ), or antibodieswith the two phosphoisoforms of Cdk2 (arrowheads 1 and 2).
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Copyright © 2000 by Academic Press. All rightcyclin J. The observed functional inhibition of cyclin J by
the aptamers may result from the aptamer blocking the
cyclin J–Cdk interaction, as suggested by two-hybrid experi-
ments for JA1 (data not shown). Alternatively, an aptamer
may inhibit kinase activity by another mechanism, for
example, by blocking access to the substrate. Combined,
our results indicate that JA1 and JA2 are efficient and
specific inhibitors of cyclin J function. Both aptamers bind
to cyclin J and not to other cyclins, both specifically inhibit
cyclin J-associated kinase activity from embryo extracts,
and both are able to specifically inhibit cyclin J function in
a yeast assay.
Cyclin J Aptamers and Antibodies Inhibit
the Syncytial Cell Cycles
To determine the effects of inhibiting cyclin J function in
vivo, we injected cyclin J aptamers or affinity-purified
cyclin J antibodies into syncytial wild-type Drosophila
embryos. We chose to inject purified peptides fused to the
trxA platform because previous results had suggested that
trxA peptides have higher affinity for their targets than the
peptides alone (Cohen et al., 1998). We previously showed
that expression of trxA-fused control peptides in Drosoph-
ila does not cause overt phenotypes during embryogenesis
and later development (Kolonin and Finley, 1998). After
injection with the aptamers or antibodies, embryos were
incubated for variable times before fixation to allow nuclei
to proceed through additional cycles. Localization of the
injected peptides or antibodies was determined by immu-
nofluorescence. For each injected agent we stained approxi-
mately 200 embryos with a DNA-staining reagent, Hoechst
33258, to look for cell cycle defects that colocalize with the
FIG. 6. Peptide aptamers JA1 and JA2 inhibit cyclin J in yeast.
Log-phase cultures of cln2 cells expressing Drosophila cyclin J
CycJ) or cyclin E (CycE) and carrying a plasmid for galactose-
nducible expression of trxA-fused control peptide, PepC2, or
ptamers JA1 or JA2 were serially diluted by factors of 10 as
ndicated, and equal amounts were spotted onto glucose plates
Glu), as a loading control, or galactose plates (Gal) to induce
xpression of peptides. The amount of growth in each spot repre-
ents the ability of a cyclin to complement yeast growth.FIG. 5. Peptide aptamers JA1 and JA2 inhibit cyclin J-associated
kinase. Protein complexes were immunoprecipitated from wild-
type 0- to 3-h-old embryos (a) or heat-shocked 3- to 20-h-old
hsp70-GAL4/UAS-cycJ embryos (b, c), using affinity-purified cy-
lin J antibodies (IP-CycJ) or antibodies specific for Drosophila
cyclin B (IP-CycB) or cyclin E (IP-CycE). The precipitates were
subjected to H1 kinase assays in the presence of buffer (lanes (a) 1;
(b) 1, 6, 11; and (c) 1, 5); 10 mM His6-trxA-tagged control peptide
epC2 (lanes (a) 2 and (b) 2, 7, 12, 16, 20, 24); the indicated
is6-trxA-tagged cyclin J aptamers (JA1 or JA2) at 1 mM (lanes (a) 3,
, and (b) 3, 8, 13, 17, 21, 25), 3 mM (lanes (a) 4, 7, and (b) 4, 9, 14,
8, 22, 26), or 10 mM (lanes (a) 5, 8, and (b) 5, 10, 15, 19, 23, 27); or
MBP-tagged Dap at 50 nM (lanes (c) 2, 6), 3 mM (lanes (c) 3, 7), or 10
mM (lanes (c) 4, 8). The position of phosphorylated H1 (arrowhead)injection site.







































668 Kolonin and FinleyAs shown for representative embryos in Fig. 7, injection
of the cyclin J aptamers or antibodies resulted in profound
effects on the syncytial cycles. Telophase chromatin
bridges near the injection site were induced at high fre-
quency by both the aptamers and the cyclin J antibodies
(Figs. 7d, 7f, 7h, and 7j). In addition to the chromosome
segregation defects, the cyclin J aptamers and antibodies
caused an apparent delay in progression through mitosis. In
many of the embryos that displayed localized staining for
the aptamer or antibody, nuclei proximal to the injection
site were at an early mitotic stage, whereas nuclei distal to
the injection site had proceeded to progressively later stages
(e.g., Fig. 7f ). The gradient of mitotic progression and the
higher frequency of chromatin bridges near the injection
site suggest that the effect of the cyclin J inhibitors is dosage-
dependent. Injection of two control trxA-fused peptides that
do not interact with cyclin J (PepC2 and cyclin D aptamer,
DA2), or of preimmune serum, did not significantly interfere
with the nuclear cycles (Figs. 7a and 7b; Table 1).
Injected trxA-fused peptides rapidly diffused throughout
the embryo and were no longer localized to the injection
site within ;20 min after injection (data not shown).
Consistent with this, we observed local cell cycle defects
only when embryos were fixed within 10 min of peptide
injection. To quantify the effects on cell cycle progression
in embryos fixed later than 10 min after injection, we
scored the cell cycle stages and the frequencies of chroma-
tin bridges among all injected embryos (Table 1). Cyclin J
aptamers and antibodies each caused chromatin bridges
even in the embryos that did not display localized defects.
For example, while only 3–7% of the embryos injected with
the control peptides or preimmune serum had chromatin
bridges; this frequency was increased to 24% (at least
threefold) by JA1 and to 16% (two- to fivefold) by JA2 (Table
1). Forty-one percent of the embryos injected with cyclin J
antibodies had chromatin bridges, sixfold over the control
injections (Table 1). The cyclin J aptamers and antibodies
also significantly increased the overall frequency of em-
bryos with nuclei in mitosis (Table 1). For example, the
frequency of embryos with nuclei undergoing mitosis in-
creased from approximately 54% for the control peptides to
78% for each cyclin J aptamer. The injected cyclin J
antibodies had a similar effect. In contrast, the frequencies
of each cell cycle stage in embryos injected with the control
peptides or serum were not significantly different from
those observed for uninjected wild-type embryos (Table 1)
(Edgar et al., 1994). These results suggest that a cyclin
J-associated kinase activity is required for normal nuclear
divisions during early embryonic development.
DISCUSSION
Peptide Aptamers to Study Protein Function
in Early Embryos
The mechanisms that regulate the earliest division cycles
of Drosophila embryogenesis are poorly characterized. This
Copyright © 2000 by Academic Press. All rights in part because of the technical challenges involved in
tudying the maternally encoded cell cycle regulators that
rive these cycles. Loss-of-function mutations in the genes
ncoding these regulators are often difficult to study in the
arly embryo because they have essential functions at other
tages of development. An effective alternative approach to
tudy these cycles is to inject embryos with small mol-
cules or antibodies that inactivate specific proteins (Schu-
iger and Edgar, 1994; Su et al., 1997). Here we applied a
wo-hybrid approach to isolate peptide aptamers that spe-
ifically inhibit cyclin J, a putative cell cycle regulator
ound in the early embryo. The phenotypes induced by
njection of the cyclin J aptamers were specific: they were
ot observed with control peptides, and they could be
henocopied by injecting antibodies specific for cyclin J.
he specificity was further supported by the fact that no
bnormal phenotypes were detected upon expression of the
yclin J aptamers from heat-shock-inducible transgenes at
ater stages of development when cyclin J is not present
data not shown). In contrast, aptamers directed at Cdk1 or
dk2 cause predicted developmental defects when ex-
ressed from transgenes later in development (Kolonin and
inley, 1998). The specificity of peptide aptamers suggests
hat they may be used to target proteins in vivo in much the
ame way antibodies have been used. For example, injection
f inhibitory antibodies has been a useful approach to probe
rotein function, particularly in systems in which analysis
f loss-of-function mutations is difficult or impractical,
uch as in cultured vertebrate cells and vertebrate and
nvertebrate embryos. Compared with antibodies, however,
eptide aptamers are relatively easy to isolate and charac-
erize. Moreover, the two-hybrid system also provides
n assay to identify peptide aptamers that disrupt spe-
ific protein–protein interactions (Caponigro et al., 1998;
abbrizio et al., 1999; Geyer et al., 1999; Norman et al.,
999; Kolonin et al., 2000). This strategy may be useful for
horough characterization of other proteins involved in
ultiple protein interactions in the early embryo.
Cyclin J Is Required for the Rapid Nuclear Cycles
in the Early Embryo
The division cycles of early Drosophila embryogenesis
normally lack gap phases, have very rapid S phases, and lack
some of the checkpoint controls found in later cell cycles
(reviewed in Foe et al., 1993). In later cell cycles specific
Cdk/cyclin complexes are known to control the length of
gap phases, S phase, and various checkpoints. Thus, the
unique features of the early cycles are likely to be mediated
either by novel regulation of the Cdks and cyclins that also
operate at other times during development or by embryo-
specific Cdks or cyclins. Here we have shown that cyclin J
and an associated kinase activity are present predominantly
during early embryogenesis. This is in contrast to other
known cyclins that are active throughout embryogenesis
(Lehner and O’Farrell, 1989; Whitfield et al., 1990; Richard-
son et al., 1993; Jacobs et al., 1998). Thus, cyclin J is a





669Cyclin J in Early Drosophila EmbryogenesisFIG. 7. Cyclin J aptamers and antibodies inhibit the syncytial cell cycles. Embryos were injected with control cyclin D aptamer DA2
a, b, i), cyclin J aptamers JA1 (c, d, j) or JA2 (e, f ), or affinity-purified cyclin J antibodies (g, h). After 10 min to allow progression of the nuclei
hrough the cell cycle, the embryos were fixed and stained for trxA-fused peptides (a, c, e), IgGs (g), or DNA (b, d, f, h–j). The injection site
s on the left in all embryos. Local concentration of the injected agent is visible (a, c, e, g). DNA staining reveals chromatin bridges
arrowheads) induced in embryos injected with JA1 (d) and, at higher magnification in (j), JA2 (f ) and cyclin J antibodies (h).
































670 Kolonin and Finleycandidate early embryo-specific cell cycle regulator. Con-
sistent with this possibility, we found that injection of early
embryos with specific cyclin J inhibitors disrupts progres-
sion through the rapid division cycles. Also, whereas other
cyclins are able to induce progression through the cell cycle
when overexpressed in late embryogenesis (Lehner et al.,
991; Knoblich et al., 1994; Sprenger et al., 1997), we
etected no abnormal cell divisions when cyclin J was
ctopically expressed in the embryo after the endogenous
rotein was degraded. Combined, our results suggest that
yclin J is required for early embryogenesis but not for cell
ivisions after cellularization.
Possible Roles for Cyclin J
The primary Cdk partner of cyclin J in the early embryo
is Cdk2. A view supported by studies in a number of
organisms is that the functional specificity of a Cdk/cyclin
complex resides in the cyclin subunit (Nasmyth, 1993).
However, the Cdk subunit can also determine the biologi-
cal function of the complex. In vertebrates, for example,
Cdk1/cyclin A complexes control mitotic events, whereas
Cdk2/cyclin A complexes are required for S phase (reviewed
in Pagano et al., 1992; Morgan, 1995). Moreover, although
Cdk1 and Cdk2 each complex with more than one cyclin,
all known Cdk1 complexes function in promoting M phase
while all known Cdk2 complexes function in promoting S
phase (Morgan, 1995). Thus, the association of cyclin J with
Cdk2 in the Drosophila embryo raises the possibility that
dk2/cyclin J complexes may function during S phase,
imilar to vertebrate Cdk2/cyclin A complexes. In this
egard it may be significant that the closest homolog of
yclin J is cyclin A.
The phenotypic consequences of inhibiting cyclin J are
onsistent with a possible role for cyclin J in regulating the
apid S phases in the early embryo. Inhibition of cyclin
TABLE 1
Cell Cycle Phenotypes of Injected Embryos
Injection No. scored % bridges % I
PepC2 175 6 6 4 50 6 3
DA2 176 3 6 1 43 6 4
Preimmune 220 7 6 5 47 6 15
JA1 262 24 6 11 22 6 2
JA2 212 16 6 9 22 6 6
Anti-CycJ 217 41 6 12 19 6 10
Note. Embryos in cycle 5–11 were injected with control peptid
affinity-purified cyclin J antibodies (anti-CycJ). After 0–30 min em
injected agent were classified into cell cycle stages (I, interphase; P,
morphology, as determined by Hoechst 33258 fluorescence. An em
those observed in that embryo and displayed by at least five adjacen
nuclei (Fig. 7j) were scored as having chromatin bridges. Standard d
for each injected agent.-associated kinase activity resulted in a delay in progres-
Copyright © 2000 by Academic Press. All rightion through mitosis and abnormal chromosome segrega-
ion. Nuclei entered mitosis with chromosomes remaining
nresolved, leading to telophase daughter nuclei connected
y chromatin bridges. A similar phenotype has been ob-
erved upon injection of agents that inhibit proteins re-
uired for DNA synthesis such as DNA polymerase a (Raff
and Glover, 1988) and MCM proteins (Su et al., 1997), but
not by inhibitors of transcription, protein synthesis, or
microtubule dynamics (reviewed in Schubiger and Edgar,
1994). Telophase chromatin bridges arise presumably be-
cause Drosophila embryos lack the checkpoint that in later
ycles prevents entry into mitosis in the presence of unrep-
icated or damaged DNA (Togashi and Okada, 1984; Raff
nd Glover, 1988; Sullivan et al., 1993). In addition to
nducing chromatin bridges, DNA replication inhibitors,
uch as aphidicolin, can slow progression through mitosis
n the early embryo (Raff and Glover, 1988). This can have
he net effect of increasing the number of nuclei in various
tages of mitosis, which we observed upon injection of
yclin J inhibitors. In contrast, inhibition of proteins re-
uired during mitosis causes an arrest at a specific mitotic
tage, without chromatin bridges (Schubiger and Edgar,
994; Ruden et al., 1997; Su et al., 1998). The possibility of
cyclin J being an early embryo-specific S phase regulator
seems particularly intriguing given the fact that genome
duplication is proceeding at a uniquely rapid pace in the
syncytium. The phenotypes resulting from cyclin J loss-of-
function mutations may provide additional information on
the precise cell cycle function of this unique cyclin.
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